These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6373316)

  • 21. Effect of insulin suppositories in type I diabetic patients (preliminary communication).
    Hildebrandt R; Ilius A; Lotz U; Schliack V
    Exp Clin Endocrinol; 1984 Apr; 83(2):168-72. PubMed ID: 6373319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twenty-four hour blood glucose profiles during insulin and insulin plus aprotinin subcutaneous administration in type I diabetes.
    Lunetta M; Napoli E; Sudano L; Leonardi R; Mughini L
    Horm Metab Res; 1986 Mar; 18(3):182-4. PubMed ID: 2422103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Insulin-induced edema in adolescents with type 1 diabetes mellitus].
    Saule H
    Dtsch Med Wochenschr; 1991 Aug; 116(31-32):1191-4. PubMed ID: 1860423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reproducibility of insulin dosage on consecutive days of blood glucose control by an artificial beta-cell in brittle diabetic patients.
    Bruns W; Bombor H; Jutzi E; Ratzmann KP; Schulz B; Abel P; Fischer U
    Diabetes Care; 1983; 6(2):112-7. PubMed ID: 6343014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe hypoglycemia as a short-term side-effect of the somatostatin analog SMS 201-995 in insulin-dependent diabetes mellitus.
    Navascuès I; Gil J; Pascau C; Senen D; Serrano-Rios M
    Horm Metab Res; 1988 Dec; 20(12):749-50. PubMed ID: 3065203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of 24-hour insulin infusion pattern by an artificial endocrine pancreas for intravenous insulin infusion with a miniature pump.
    Kølendorf K; Christiansen JS; Bojsen J; Svendsen PA; Teglbjaerg LL
    Horm Metab Res; 1981 May; 13(5):245-9. PubMed ID: 7021384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of the artificial B-cell (Biostator) in improving insulin therapy in unstable insulin-dependent diabetes.
    Ratzmann KP; Bruns W; Schulz B; Zander E
    Diabetes Care; 1982; 5(1):11-7. PubMed ID: 6754298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Twenty-four-hour metabolic profiles in diabetic children receiving insulin injections once or twice daily.
    Werther GA; Jenkins PA; Turner RC; Baum JD
    Br Med J; 1980 Aug; 281(6237):414-8. PubMed ID: 7000260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative pharmacodynamic studies of insulin Maxirapid Polfa and Actrapid MC Novo using Biostator GCIIS].
    Sieradzki J
    Pol Tyg Lek; 1984 Apr; 39(18):615-7. PubMed ID: 6399370
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of an artificial pancreas as a tool to determine subcutaneous insulin doses in juvenile diabetes.
    Lambert AE; Buysschaert M; Lambotte L
    Diabetes Care; 1979; 2(3):256-64. PubMed ID: 510117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Individualized insulin therapy in children and adolescents with type 1 diabetes.
    Becker D
    Acta Paediatr Suppl; 1998 Oct; 425():20-4. PubMed ID: 9822189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of a multiple insulin injection regimen in teenagers with insulin-dependent diabetes. Carbohydrate and lipid oxidation measured by continuous indirect calorimetry.
    Kimura S; Nose O; Tajiri H; Miki K; Yabuuchi H; Shichiri M; Harada T
    Diabetes Res Clin Pract; 1987 Nov; 4(1):77-9. PubMed ID: 3319469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circadian rhythm of growth hormone, free and total insulin during the treatment with artificial B-cell (Biostator GCIIS).
    Sieradzki J; Szybiński Z; Izworski A; Gołda W
    Endokrynol Pol; 1983; 34(2):73-80. PubMed ID: 6354700
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical usefulness of artificial endocrine pancreas "Biostator" in management of unstable diabetics.
    Ohno M; Ito K; Saito S; Kageyama S; Ikeda Y; Tanese T; Abe M
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():723-32. PubMed ID: 6393446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Combined use of automatic systems for treating patients with type 1 diabetes mellitus].
    Perelygina AA; Antsiferov MB; Starostina EG
    Probl Endokrinol (Mosk); 1987; 33(5):3-6. PubMed ID: 3422932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computer-aided systems in the management of type I diabetes: the application of a model-based strategy.
    Salzsieder E; Albrecht G; Fischer U; Rutscher A; Thierbach U
    Comput Methods Programs Biomed; 1990; 32(3-4):215-24. PubMed ID: 2249420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DIABETEX decision module 2--calculation of insulin dose proposals and situation recognition by means of classifiers.
    Stadelmann A; Abbas S; Zahlmann G; Bruns W; Hennig I
    Comput Methods Programs Biomed; 1990; 32(3-4):333-7. PubMed ID: 2249433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo comparison of different algorithms for the artificial beta-cell.
    Fischer U; Detschew W; Jutzi E; Albrecht G; Abel P; Salzsieder E; Freyse EJ; Frenzel S; Lemke K
    Artif Organs; 1985 May; 9(2):173-9. PubMed ID: 4015454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Once- versus twice-daily insulin for diabetic children.
    Werther GA; Baum JD
    Br Med J; 1978 Jul; 2(6129):52. PubMed ID: 678805
    [No Abstract]   [Full Text] [Related]  

  • 40. Exercise: a vital component for patients on the Biostator.
    Summers S
    Diabetes Educ; 1984; 10(2):22-4. PubMed ID: 6564950
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.